Ember Therapeutics Stock Buy Hold or Sell Recommendation
| EMBT Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Ember Therapeutics is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Ember Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Ember Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Ember Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ember and provide practical buy, sell, or hold advice based on investors' constraints. Ember Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Ember |
Execute Ember Therapeutics Buy or Sell Advice
The Ember recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ember Therapeutics. Macroaxis does not own or have any residual interests in Ember Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ember Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
1 Year |
Risk Tolerance
I am an average risk taker |
 |  |
Not Rated
Ember Therapeutics Trading Alerts and Improvement Suggestions
| Ember Therapeutics generated a negative expected return over the last 90 days | |
| Ember Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (23.24 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ember Therapeutics currently holds about 71.22 M in cash with (16.72 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.412, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 65.0% of the company shares are held by company insiders |
Ember Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ember analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ember analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Ember Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ember Therapeutics or Ember sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ember Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ember pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Ember Therapeutics Volatility Alert
At this time Ember Therapeutics exhibits very low volatility. Ember Therapeutics appears to be a penny stock. Although Ember Therapeutics may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Ember Therapeutics or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Ember instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ember Therapeutics Fundamentals Vs Peers
Comparing Ember Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ember Therapeutics' direct or indirect competition across all of the common fundamentals between Ember Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ember Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Ember Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Ember Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ember Therapeutics to competition |
| Fundamentals | Ember Therapeutics | Peer Average |
| Current Valuation | 12 M | 16.62 B |
| Shares Outstanding | 40 M | 571.82 M |
| Shares Owned By Insiders | 65.00 % | 10.09 % |
| Price To Earning | 26.61 X | 28.72 X |
| EBITDA | 9.4 M | 3.9 B |
| Net Income | (23.24 K) | 570.98 M |
| Cash And Equivalents | 71.22 M | 2.7 B |
| Cash Per Share | 0.41 X | 5.01 X |
| Total Debt | 75 K | 5.32 B |
| Debt To Equity | 0.33 % | 48.70 % |
| Current Ratio | 3.32 X | 2.16 X |
| Book Value Per Share | (0.74) X | 1.93 K |
| Cash Flow From Operations | (16.72 K) | 971.22 M |
| Number Of Employees | 3 | 18.84 K |
| Beta | 3.33 | -0.15 |
| Market Capitalization | 926.88 K | 19.03 B |
| Total Asset | 184 | 29.47 B |
| Retained Earnings | 289 K | 9.33 B |
| Working Capital | 58.61 M | 1.48 B |
| Current Asset | 83.91 M | 9.34 B |
| Current Liabilities | 25.3 M | 7.9 B |
| Net Asset | 184 |
Ember Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ember . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Ember Therapeutics Buy or Sell Advice
When is the right time to buy or sell Ember Therapeutics? Buying financial instruments such as Ember Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ember Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Funds Thematic Idea Now
Healthcare Funds
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Ember Pink Sheet Analysis
When running Ember Therapeutics' price analysis, check to measure Ember Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ember Therapeutics is operating at the current time. Most of Ember Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ember Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ember Therapeutics' price. Additionally, you may evaluate how the addition of Ember Therapeutics to your portfolios can decrease your overall portfolio volatility.